Allspring Global Investments Holdings LLC Sells 44,747 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Allspring Global Investments Holdings LLC reduced its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,043,074 shares of the company's stock after selling 44,747 shares during the period. Allspring Global Investments Holdings LLC owned about 2.10% of Prestige Consumer Healthcare worth $63,857,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Centiva Capital LP boosted its holdings in Prestige Consumer Healthcare by 4.2% in the fourth quarter. Centiva Capital LP now owns 4,174 shares of the company's stock valued at $261,000 after purchasing an additional 167 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Prestige Consumer Healthcare by 1.8% in the third quarter. Sequoia Financial Advisors LLC now owns 10,068 shares of the company's stock worth $576,000 after buying an additional 179 shares during the last quarter. Pinnacle Associates Ltd. grew its holdings in Prestige Consumer Healthcare by 0.8% during the third quarter. Pinnacle Associates Ltd. now owns 24,672 shares of the company's stock worth $1,411,000 after acquiring an additional 200 shares during the period. Pacer Advisors Inc. raised its position in Prestige Consumer Healthcare by 85.7% during the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company's stock valued at $27,000 after acquiring an additional 204 shares in the last quarter. Finally, Great West Life Assurance Co. Can lifted its holdings in Prestige Consumer Healthcare by 0.6% in the first quarter. Great West Life Assurance Co. Can now owns 43,488 shares of the company's stock valued at $2,362,000 after acquiring an additional 241 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 5,336 shares of Prestige Consumer Healthcare stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $69.00, for a total value of $368,184.00. Following the completion of the transaction, the senior vice president now owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on PBH shares. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, February 10th. TheStreet upgraded shares of Prestige Consumer Healthcare from a "c+" rating to a "b-" rating in a research report on Monday, February 12th. One equities research analyst has rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $110.00.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock traded up $0.19 during trading on Thursday, reaching $69.12. The company had a trading volume of 168,495 shares, compared to its average volume of 242,174. The firm has a market capitalization of $3.43 billion, a PE ratio of -42.15, a price-to-earnings-growth ratio of 1.86 and a beta of 0.52. The firm's 50-day simple moving average is $70.09 and its 200 day simple moving average is $63.31. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.92 and a current ratio of 3.09. Prestige Consumer Healthcare Inc. has a 1-year low of $55.96 and a 1-year high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, beating analysts' consensus estimates of $1.04 by $0.02. The company had revenue of $282.74 million during the quarter, compared to analysts' expectations of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. Prestige Consumer Healthcare's revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the business posted $1.04 EPS. As a group, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.